Direct Marketing

Clinical Medicine and Pharmacology sends issue announcements and calls for papers to registered users and may contact scholars whose professional work closely matches a proposed clinical or pharmacological topic. These communications must identify the journal and publisher accurately, describe the opportunity honestly and allow recipients to stop optional messages. An invitation is not a clinical endorsement or an acceptance decision.

Clinical relevance and an identifiable sender

An invitation names CMP, Jandoo Press and a verifiable journal contact. Selection should connect to the recipient’s stated professional interests, such as a clinical specialty, trial method or pharmacological research area. A general campaign must not falsely claim that an editor has evaluated the recipient’s study. A conference organiser or other representative can speak for CMP only within a recorded authorisation.

Claims about publication and costs

Messages state the relevant scope, independent assessment and publication arrangements accurately. The standard APC is USD 450; approved 50 percent assistance leaves USD 225 payable. A campaign referring to assistance links to the full eligibility and non-stacking rules. No current institutional partner exists for CMP, and a clinician’s employer is not presented as one merely because it appears in an author affiliation.

Indexing, metrics, editorial appointments and partnerships require a current evidential basis. A Scopus or DOAJ application is not acceptance. Neither a treatment’s commercial potential nor a sponsor’s interest can justify a claim of guaranteed publication. A special-issue call identifies its authorised guest editors, submission route and applicable financial terms; the invitation does not waive ethics, trial-registration or independent-review requirements.

Professional contact sources

Staff may identify a relevant researcher through a publicly displayed professional email where the message directly relates to clinical or pharmacological work. The campaign record must retain the source URL, access date and reason for relevance. A clinical directory may contain patient-service addresses or contact restrictions; those are not a licence to solicit a researcher indiscriminately.

Source terms, access controls, anti-scraping restrictions and indications that an address is not for solicitation must be respected. The office does not buy indiscriminate lists, infer private addresses, bypass restrictions or collect unrelated personal contacts. Publication of an address does not supply every legal basis or permission needed for the proposed campaign. Recipient lists are not sold and bulk delivery must not reveal other recipients’ addresses.

Choice and suppression

Each optional message offers an unsubscribe link or a clear reply instruction. Requests sent to cmpeditorialoffice@jandoopress.com are also accepted. Staff stop further promotion promptly, remove unnecessary mailing-list details within 30 days and retain only the minimum suppression record needed to prevent re-enrolment. A previous registration does not override a later objection or any consent requirement applicable to the campaign.

Necessary manuscript, review, invoice or correction correspondence may continue for its distinct purpose. An unsubscribe request cannot require surrendering article access or withdrawing a paper. CMP does not pressure an author through invented scarcity of publication places. Approved benefits are recorded, and an unauthorised intermediary’s promise is checked rather than automatically charged to the author.

Misleading invitations and clinical integrity

Forward suspected impersonation, an inaccurate invitation or a misleading sender’s details to cmpeditorialoffice@jandoopress.com with the message and relevant links. The publisher examines representations made in its name and corrects material it controls. A marketing complaint must not influence assessment of the recipient’s research. If a message implies that a medicine, device or provider is endorsed by CMP, the office distinguishes the published evidence from unauthorised promotional use of the journal’s identity.

Last updated: 17 September 2026